Macrogenics (MGNX) Non-Current Deffered Revenue (2012 - 2025)

Macrogenics (MGNX) has reported Non-Current Deffered Revenue for 14 consecutive years, with $55.5 million the latest figure, recorded in Q4 2025.

• In Q4 2025, Non-Current Deffered Revenue changed 0.0% year-over-year to $55.5 million; the TTM figure through Dec 2025 stood at $55.5 million (changed 0.0% YoY), while the FY2025 annual figure was $55.5 million, changed 0.0% from the prior year.
• Non-Current Deffered Revenue fell to $55.5 million in Q4 2025 per MGNX's latest filing, from $55.8 million in the prior quarter.
• Across five years, Non-Current Deffered Revenue topped out at $64.3 million in Q3 2023 and bottomed at $7.3 million in Q1 2021.
• Historically, Non-Current Deffered Revenue has averaged $49.8 million across 5 years, with a median of $55.9 million in 2025.
• Annual changes were most pronounced in 2022 — Non-Current Deffered Revenue surged 690.63% — and 2024, when it declined 13.63%.
• Macrogenics' Non-Current Deffered Revenue stood at $9.6 million in 2021, then jumped by 521.2% to $59.5 million in 2022, then dropped by 0.4% to $59.2 million in 2023, then retreated by 6.31% to $55.5 million in 2024, then changed by 0.0% to $55.5 million in 2025.
• Business Quant data shows MGNX's Non-Current Deffered Revenue at $55.5 million in Q4 2025, $55.8 million in Q3 2025, and $55.7 million in Q2 2025.